Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

INTRODUCTION: Patients with chronic kidney disease (CKD) are at heightened cardiovascular risk, which has been associated with abnormalities of bone and mineral metabolism. A deeper understanding of these abnormalities should facilitate improved treatment strategies and patient-level outcomes, but a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lioufas, Nicole, Toussaint, Nigel D, Pedagogos, Eugenia, Elder, Grahame, Badve, Sunil V, Pascoe, Elaine, Valks, Andrea, Hawley, Carmel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398689/
https://www.ncbi.nlm.nih.gov/pubmed/30796122
http://dx.doi.org/10.1136/bmjopen-2018-024382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398689/
https://www.ncbi.nlm.nih.gov/pubmed/30796122
http://dx.doi.org/10.1136/bmjopen-2018-024382

Ejemplares similares